These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Treatment of resistant Hodgkin's disease with CCNU, etoposide and prednimustine (CEP). Szántó I; Fleischmann T; Eckhardt S Oncology; 1991; 48(6):456-8. PubMed ID: 1749581 [TBL] [Abstract][Full Text] [Related]
50. Probability of cure in elderly Hodgkin's disease patients. Levis A; Depaoli L; Urgesi A; Bertini M; Orsucci L; Vitolo U; Buchi G; Gallamini A; Gavarotti P; Novarino A; Rota Scalabrini D; Mazza U; Pileri A; Sannazzari GL; Resegotti L Haematologica; 1994; 79(1):46-54. PubMed ID: 15378948 [TBL] [Abstract][Full Text] [Related]
51. [Systemic amyloidosis in Hodgkin's disease: presentation of 2 cases]. Peña JM; de Miguel E; González JJ; García-Alegría J; Barbado FJ; Arnalich F; Ortiz Vázquez J Rev Clin Esp; 1986 Nov; 179(7):359-61. PubMed ID: 3797748 [No Abstract] [Full Text] [Related]
52. Hodgkin's disease--from pathology specimen to cure. Diehl V N Engl J Med; 2007 Nov; 357(19):1968-71. PubMed ID: 17989391 [No Abstract] [Full Text] [Related]
53. Effect of an intensive chemotherapy followed by mediastinal irradiation on pulmonary and cardiac function in advanced Hodgkin's disease. Villani F; Fede Catania A; Laffranchi A; Maffioli L; Viviani S; Bonfante V Cancer Invest; 2003 Apr; 21(2):185-92. PubMed ID: 12743983 [TBL] [Abstract][Full Text] [Related]
54. [Hodgkin's disease in children; treatment results with or without radiotherapy]. Ned Tijdschr Geneeskd; 1986 Jun; 130(26):1204-5. PubMed ID: 3736698 [No Abstract] [Full Text] [Related]
55. Burkitt leukaemia following chemoradiotherapy in a patient with Hodgkin's disease. Brenner B; Nagler A; Ben-Arieh Y; Steiner M Clin Lab Haematol; 1986; 8(2):163-4. PubMed ID: 3731730 [No Abstract] [Full Text] [Related]
56. [Report on the First International Symposium on Hodgkin's Lymphoma from October 2-3, 1987 in Köln (East Germany)]. Anger G Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):609-11. PubMed ID: 2465982 [No Abstract] [Full Text] [Related]
57. High relapse rate after a brief chemotherapy course and involved-field radiotherapy in early-stage Hodgkin lymphoma. Magagnoli M; Balzarotti M; Siracusano LV; Spina M; Isa L; Morenghi E; Tirelli U; Santoro A Leuk Lymphoma; 2007 Dec; 48(12):2444-6. PubMed ID: 17943600 [No Abstract] [Full Text] [Related]
58. Exceptionally long disease-free period in a case of Sézary syndrome after combined treatment with leukapheresis and chemotherapy. Di Guglielmo R; Miliani A; Avanzi G; Cozzolino F; Duminuco M; Vannucci R; Occhini U Haematologica; 1987; 72(6):541-3. PubMed ID: 3126113 [No Abstract] [Full Text] [Related]
59. Hodgkin's and Castleman's disease in a patient with systemic mastocytosis. Saletti P; Ghielmini M; Scali G; Pedrinis E; Guéneau M; Cavalli F Ann Hematol; 1999 Feb; 78(2):97-100. PubMed ID: 10089028 [TBL] [Abstract][Full Text] [Related]
60. Tolerance to chemotherapy after prior irradiation for Hodgkin's disease. Curran RE; Johnson RE Ann Intern Med; 1970 Apr; 72(4):505-9. PubMed ID: 5437632 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]